Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-05-13
2008-05-13
Gupta, Anish (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S317000, C530S328000, C530S329000
Reexamination Certificate
active
07371724
ABSTRACT:
Analogues of the amino acid sequence KAPREKY and their use in screening for compounds which interacts with FcεRIα.
REFERENCES:
patent: 5965709 (1999-10-01), Presta et al.
patent: 6777388 (2004-08-01), Grasso et al.
patent: 2002/0076420 (2002-06-01), Caplan et al.
patent: WO01/71342 (2001-09-01), None
patent: WO97/10004 (1997-03-01), None
patent: WO01/71342 (2001-09-01), None
Nechansky et al., “Inhibition of Antigen-Induced Mediator Release from IgE-Sensitized Cells by a Monoclonal Anti-FcεRI α-Chain Receptor Antibody: Implications for the Involvement of the Membrane-Proximal α-Chain Region in FcεRI-Mediated Cell Activation,” J Immunol, vol. 166, pp. 5979-5990 (2001).
Buenemann Christoph
Peters Carsten
Weigand Klaus
Gupta Anish
Ha Julie
Novartis AG
LandOfFree
KAPREKY peptidomimetics and analogues thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with KAPREKY peptidomimetics and analogues thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and KAPREKY peptidomimetics and analogues thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2778694